CANT1 and cancer: The high frequency of missense mutations in CANT1 in patients with Desbuquois dysplasia suggests that disruptions in this gene’s function may lead to significant alterations in bone development, similar to how they influence cancer progression through signaling pathways, such as NF-κB.